The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Chlorophenyl)-1-((4aS,8S,8aR)-8-((S)-3-hydroxypyrrolidin-1-yl)-4-((isoxazol-3-ylmethyl)sulfonyl)octahydroquinoxalin-1(2H)-yl)-ethanone ID: ALA4096405
PubChem CID: 137656159
Max Phase: Preclinical
Molecular Formula: C24H31ClN4O5S
Molecular Weight: 523.06
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Cc1ccc(Cl)cc1)N1CCN(S(=O)(=O)Cc2ccon2)[C@H]2CCC[C@H](N3CC[C@H](O)C3)[C@H]21
Standard InChI: InChI=1S/C24H31ClN4O5S/c25-18-6-4-17(5-7-18)14-23(31)28-11-12-29(35(32,33)16-19-9-13-34-26-19)22-3-1-2-21(24(22)28)27-10-8-20(30)15-27/h4-7,9,13,20-22,24,30H,1-3,8,10-12,14-16H2/t20-,21-,22-,24+/m0/s1
Standard InChI Key: LKHLWYRFNPPXRF-GRSYGWAWSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
32.3162 -24.5446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4990 -24.5446 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.9076 -25.2523 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4355 -19.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7426 -20.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2425 -21.3160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4519 -21.1320 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4127 -22.1086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7274 -22.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7575 -23.3513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4728 -23.7295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1623 -23.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8777 -23.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5672 -23.2471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5370 -22.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8176 -22.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1322 -22.4867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7863 -21.2399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4245 -20.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1423 -19.9692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3257 -20.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1033 -20.7868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9381 -19.2826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6316 -18.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8258 -18.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3273 -19.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6365 -19.8164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1263 -21.6680 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
32.1552 -24.1154 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
30.5159 -17.6640 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.8095 -24.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5970 -19.2901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8416 -25.7964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2034 -26.3013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4863 -27.0680 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3029 -27.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5245 -26.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 8 1 0
12 17 1 0
16 18 1 1
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
4 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 4 1 0
17 28 1 1
12 29 1 1
25 30 1 0
11 2 1 0
2 31 1 0
20 32 1 6
31 33 1 0
33 34 2 0
34 35 1 0
35 36 1 0
36 37 2 0
37 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 523.06Molecular Weight (Monoisotopic): 522.1704AlogP: 1.90#Rotatable Bonds: 6Polar Surface Area: 107.19Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.02CX LogP: 1.36CX LogD: 0.64Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.62Np Likeness Score: -0.83
References 1. Soeberdt M, Molenveld P, Storcken RP, Bouzanne des Mazery R, Sterk GJ, Autar R, Bolster MG, Wagner C, Aerts SN, van Holst FR, Wegert A, Tangherlini G, Frehland B, Schepmann D, Metze D, Lotts T, Knie U, Lin KY, Huang TY, Lai CC, Ständer S, Wünsch B, Abels C.. (2017) Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo., 60 (6): [PMID:28218838 ] [10.1021/acs.jmedchem.6b01868 ]